News one will get in the business mail.


Merck Recalls TEMODAR and Temozolomide Bottles With Cracked Childproof Caps

Merck, in conjunction with Consumer Product Safety Commission, is recalling TEMODAR® and temozolomide bottles with cracks in the child-resistant caps. Merck believes that approximately 1,100 bottles out of an estimated 276,000 distributed bottles of TEMODAR and temozolomide capsules (generic), medicines used to treat adults with certain brain cancer tumors, could potentially have cracked caps. The recall affects the medicine manufactured and distributed by Merck as TEMODAR in addition to the temozolomide capsules manufactured and packaged by Merck but sold and distributed by Sandoz, under the Sandoz label. Merck’s TEMODAR in sachets (or pouches) are not affected. 

Merck is asking all patients to inspect all bottles of TEMODAR (temozolomide) capsules and all bottles of temozolomide capsules for cracks in the child-resistant bottle caps. If cracks are found, Merck advises keeping the bottles out of the reach of children. The quality of the medication in the bottles is not affected and patients may continue to use the drug as directed. Instructions for obtaining a replacement cap are provided in the press release on Merck’s website.